Search Results - "Xu, Qingnian"

Refine Results
  1. 1

    Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis by Yang, Zongguo, Zhuang, Liping, Lu, Yunfei, Xu, Qingnian, Tang, Bozong, Chen, Xiaorong

    Published in Oncotarget (15-03-2016)
    “…Basal core promoter (BCP) A1762T/G1764A dual mutations in hepatocarcinogenesis remain controversial. Published studies up to June 1, 2015 investigating the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Clinical features and factors associated with outcomes of patients infected with a Novel Influenza A (H7N9) virus: a preliminary study by Chen, Xiaorong, Yang, Zongguo, Lu, Yunfei, Xu, Qingnian, Wang, Qiang, Chen, Liang

    Published in PloS one (17-09-2013)
    “…The present study aimed to analyze clinical features and factors associated with treatment outcomes of H7N9 influenza A virus infection. The clinical progress…”
    Get full text
    Journal Article
  4. 4

    Epidemiology and clinical course of COVID-19 in Shanghai, China by Shen, Yinzhong, Zheng, Fang, Sun, Danfeng, Ling, Yun, Chen, Jun, Li, Feng, Li, Tao, Qian, Zhiping, Zhang, Yuyi, Xu, Qingnian, Liu, Li, Huang, Qin, Shan, Fei, Xu, Lie, Wu, Jun, Zhu, Zhaoqin, Song, Zhigang, Li, Shenyang, Shi, Yuxin, Zhang, Jianliang, Wu, Xueyun, Mendelsohn, Joshua B., Zhu, Tongyu, Lu, Hongzhou

    Published in Emerging microbes & infections (01-01-2020)
    “…Background: Novel coronavirus pneumonia (COVID-19) is prevalent around the world. We aimed to describe epidemiological features and clinical course in…”
    Get full text
    Journal Article
  5. 5

    Efficacy and safety of peginterferon plus ribavirin for patients aged ≥ 65 years with chronic hepatitis C: A systematic review and meta-analysis by Yang, Zongguo, Zhuang, Liping, Yang, Lei, Liu, Cheng, Lu, Yunfei, Xu, Qingnian, Chen, Xiaorong, Chen, Liang

    “…Summary Methods Studies up to August 30, 2012 of the efficacy and safety of peginterferon plus ribavirin therapy in CHC patients aged ≥ 65 years were…”
    Get full text
    Journal Article
  6. 6

    Clinical progression of patients with COVID-19 in Shanghai, China by Chen, Jun, Qi, Tangkai, Liu, Li, Ling, Yun, Qian, Zhiping, Li, Tao, Li, Feng, Xu, Qingnian, Zhang, Yuyi, Xu, Shuibao, Song, Zhigang, Zeng, Yigang, Shen, Yinzhong, Shi, Yuxin, Zhu, Tongyu, Lu, Hongzhou

    Published in The Journal of infection (01-05-2020)
    “…•Most of the COVID-19 cases are mild.•The estimated median duration of fever was 10 days.•Radiological improvement was observed on 14 days after onset of…”
    Get full text
    Journal Article
  7. 7

    Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients by Yang, Zongguo, Shi, Jia, He, Zhang, Lü, Ying, Xu, Qingnian, Ye, Chen, Chen, Shishi, Tang, Bozong, Yin, Keshan, Lu, Yunfei, Chen, Xiaorong

    Published in Aging (Albany, NY.) (10-04-2020)
    “…This study aimed to investigate the potential parameters associated with imaging progression on chest CT from coronavirus disease 19 (COVID-19) patients. The…”
    Get full text
    Journal Article
  8. 8

    Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19 by Chen, Jun, Xia, Lu, Liu, Li, Xu, Qingnian, Ling, Yun, Huang, Dan, Huang, Wei, Song, Shuli, Xu, Shuibao, Shen, Yingzhong, Lu, Hongzhou

    Published in Open forum infectious diseases (01-07-2020)
    “…Abstract Background We aimed to evaluate the antiviral activity and safety of darunavir/cobicistat (DRV/c) in treating COVID-19 patients. Methods In this…”
    Get full text
    Journal Article
  9. 9

    Paeoniflorin regulates macrophage activation in dimethylnitrosamine-induced liver fibrosis in rats by Chen, Xiaorong, Liu, Cheng, Lu, Yunfei, Yang, Zongguo, Lv, Zhen, Xu, Qingnian, Pan, Qi, Lu, Lingqing

    Published in BMC complementary and alternative medicine (13-12-2012)
    “…Macrophages in other organs (e.g. kidneys, lungs, and spleen, et. al) have rarely been reported in the development of liver fibrosis. Therefore, it is…”
    Get full text
    Journal Article
  10. 10

    HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus by Park, Cheol-Keun, Tang, Bozong, Xu, Qingnian, Lu, Yunfei, Yang, Zongguo, Chen, Xiaorong

    Published in Disease markers (01-01-2015)
    “…Objective. This study aimed to evaluate the relationships between long noncoding RNAs (lncRNAs) in tumor tissues and hepatocellular carcinoma (HCC)…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials by Yu, Yongchun, Tang, Bozong, Xu, Qingnian, Lu, Yunfei, Liao, Xian, Yang, Zongguo, Chen, Xiaorong

    “…Background and Aims. Traditional Chinese medicine (TCM) therapy for hepatocellular carcinoma remains controversial. This study aimed to evaluate the efficacy…”
    Get full text
    Journal Article
  14. 14

    A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19 by Chen, Jun, Liu, Danping, Liu, Li, Liu, Ping, Xu, Qingnian, Xia, Lu, Ling, Yun, Huang, Dan, Song, Shuli, Zhang, Dandan, Qian, Zhiping, Li, Tao, Shen, Yinzhong, Lu, Hongzhou

    “…To evaluate the efficacy and safety of hydroxychloroquine (HCQ) in the treatment of patients with moderate coronavirus disease 2019 (COVID-19). We…”
    Get full text
    Journal Article
  15. 15

    Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials by Lin, Jiang, Xu, Qingnian, Lu, Yunfei, Yang, Zongguo, Zhang, Jianliang, Tang, Bozong, Chen, Xiaorong

    “…Background. The complementary and alternative medicines in treatment of diarrhea-predominant irritable bowel syndrome (IBS-D) are controversial. Methods. We…”
    Get full text
    Journal Article
  16. 16

    Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats by Liu, Cheng, Yang, Zongguo, Wang, Lei, Lu, Yunfei, Tang, Bozong, Miao, Hui, Xu, Qingnian, Chen, Xiaorong

    Published in BMC gastroenterology (16-11-2015)
    “…Liver sinusoidal endothelial cells (SECs), hepatic stellate cells (HSCs) and Kupffer cells (KCs) are involved in the development of liver fibrosis and…”
    Get full text
    Journal Article
  17. 17

    Effects and Tolerance of Silymarin (Milk Thistle) in Chronic Hepatitis C Virus Infection Patients: A Meta-Analysis of Randomized Controlled Trials by Xu, Qingnian, Lu, Yunfei, Zhuang, Liping, Yang, Zongguo, Chen, Xiaorong

    Published in BioMed research international (01-01-2014)
    “…Objective. This study aimed to evaluate the efficacy and safety of silymarin on chronic hepatitis C virus- (HCV-) infected patients. Methods. Randomized…”
    Get full text
    Journal Article
  18. 18

    Traditional Chinese Medicine Formulation Therapy in the Treatment of Coronavirus Disease 2019 (COVID-19) by Shi, Jia, Lu, Yunfei, Zhang, Yuan, Xia, Lu, Ye, Chen, Lü, Ying, Chen, Shishi, Xu, Qingnian, Tang, Bozong, Yin, Keshan, Zhang, Jing, Chen, Xiaorong, Yang, Zongguo

    “…This study aimed to investigate the efficacy of Traditional Chinese Medicine (TCM) decoction with different intervention timepoints in the treatment of…”
    Get more information
    Journal Article
  19. 19

    Elevation of serum GGT and LDH levels, together with higher BCLC staging are associated with poor overall survival from hepatocellular carcinoma: a retrospective analysis by Yang, Zongguo, Ye, Peiyan, Xu, Qingnian, Lu, Yunfei, Tang, Bozong, Wang, Qiang, Chen, Shishi, Chen, Xiaorong

    Published in Discovery medicine (01-06-2015)
    “…Serum biomarkers predicting prognosis have not been adequately explored in HCC patients. The aim of this study was to investigate prognostic significance of…”
    Get more information
    Journal Article
  20. 20

    Elevated serum gamma-glutamyltransferase predicts advanced histological liver damage in chronic hepatitis B by Yu, Yuan, Fan, Yaofu, Yang, Zongguo, Lu, Yunfei, Xu, Qingnian, Chen, Xiaorong

    Published in Discovery medicine (01-01-2016)
    “…Recently, several studies have demonstrated that serum gamma-glutamyltransferase (GGT) is associated with some diseases, such as chronic hepatitis B (CHB)…”
    Get more information
    Journal Article